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Abstract 
   
Leishmania parasites belong to the Trypanosomatidae family and are causative 
agents of leishmaniasis. During their life cycle, Leishmania shifts between two different 
morphological forms, promastigotes (insect vector) and amastigotes (mammalian host). 
This transition between different hosts entails extensive metabolic adaptations. The 
identification of pathways that are essential to the parasite and absent from the host is 
expected to reveal putative drug targets. In this context, the mitochondrion of 
trypanosomatids is a fascinating organelle showing a number of unique characteristics. 
These organisms contain a single, elongated and highly branched mitochondrion, 
unlike most other eukaryotes. Moreover, trypanosomatids mitochondrion houses 
metabolic pathways required for redox balance and energy production that involve 
unique enzymes. Two such proteins are directly linked to mitochondrial respiratory 
metabolism, mitochondrial fumarate reductase (LimFRD) and alternative NADH 
dehydrogenase (LiNDH2). The mFRD enzyme oxidizes NADH reducing fumarate to 
succinate. On the other hand, NDH2 enzyme catalyzes the oxidation of NADH 
transferring electrons to ubiquinone. Given the fact that these proteins do not exist in 
the mammalian host, their potential as therapeutic agents is very promising. The 
present study aims at understanding the involvement of the LimFRD and LiNDH2 
enzymes in mitochondrial metabolism of Leishmania infantum.  
In order to investigate the expression of LimFRD and LiNDH2 in L. infantum, 
specific antibodies against each of the proteins were produced. These antibodies 
detected the respective proteins, LimFRD or LiNDH2, in amastigotes and 
promastigotes developmental stages. Thereafter, the subcellular localization of the 
proteins was studied. The results obtained by indirect immunofluorescence and  
protease accessibility upon sequential digitonin solubilization show that both proteins 
are located in the mitochondrion, LimFRD in the matrix and LiNDH2 associated with 
the inner mitochondrial membrane.  
 Furthermore, the effects of overexpressing each of these enzymes in energetic 
metabolism were evaluated by oxygen consumption studies in comparison to the wild 
type. Overexpression of LiNDH2 results in increased basal oxygen consumption with 
higher activities of complex II and of enzymes that feed electrons into the first entry 
point of the respiratory chain (including LiNDH2). Moreover, the respiratory activity of 
OE_LimFRD parasites displays decreased sensitivity to KCN, a complex IV inhibitor, 
probably associated to a higher oxygen consumption that diverged into ROS 
production by LimFRD. OE_LimFRD basal respiration is similar to that observed in the 
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wild type strain being sensitive to complex II inhibitors and almost not inhibited by 
rotenone, an inhibitor of the proton-pumping complex I. Additionally, OXPHOS 
inhibitors affect growth to the same extent in wt, OE_LimFRD and OE_LiNDH2. 
Interestingly, a specific inhibitor of the alternative oxidase, SHAM, almost completely 
inhibits L. infantum growth.  
Further investigations are necessary to have a complete understanding of the 
involvement of LimFRD and LiNDH2 in mitochondrial metabolism in these parasites. 
The generation of knockout strains for LimFRD and LiNDH2 encoding genes as well as 
the determination of LiNDH2 localization will be performed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords: alternative NADH dehydrogenase; fumarate reductase; NADH oxidation; 
mitochondria; Leishmania. 
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Resumo 
 
Leishmania é um parasita que pertence à família Trypanosomatidae e é o 
principal agente causador de leishmanioses. Durante o seu ciclo de vida, o parasita 
transita entre duas formas morfológicas diferentes, promastigota (vetor inseto) e 
amastigota (hospedeiro mamífero). Esta alteração morfológica requer uma elevada 
adaptação metabólica por parte do parasita. A identificação de vias fulcrais para o 
parasita, e que não estejam presentes no hospedeiro, podem ser vistas como 
promissores alvos terapêuticos. Neste contexto, a mitocôndria dos tripanossomatídeos 
é um organelo fascinante devido às suas características peculiares e únicas. Estes 
organismos possuem apenas uma mitocôndria, sendo esta caracterizada pela sua 
forma alongada e altamente ramificada em oposição à encontrada na maioria dos 
eucariotas. Além do mais, a mitocôndria dos tripanossomatídeos possui vias 
metabólicas necessárias para o equilíbrio redox e a produção de energia que envolve 
enzimas apenas encontradas em alguns organismos. Duas dessas enzimas são a 
NADH desidrogenase (LiNDH2) e a fumarato reductase (LimFRD), que estão 
diretamente relacionadas com o metabolismo respiratório mitocondrial. A enzima 
NDH2 tem como função a oxidação de NADH transferindo os eletrões para a 
ubiquinona. Por sua vez, a mFRD oxida NADH reduzindo fumarato a sucinato. Devido 
ao facto destas proteínas não existirem no hospedeiro mamífero o seu potencial 
terapêutico é enfatizado, sendo por isso vistas como promissores alvos terapêuticos. 
Assim, o presente estudo tem como objetivo perceber o envolvimento das enzimas 
LiNDH2 e LimFRD no metabolismo mitocondrial de Leishmania infantum. 
De forma a investigar a expressão das proteínas LimFRD e LiNDH2 em L. 
infantum, produziram-se anticorpos específicos contra cada uma delas. Verificou-se 
que ambas as proteínas são expressas durante as duas fases de desenvolvimento do 
parasita. Posteriormente, foi abordada a localização das proteínas recorrendo à 
imunofluorescência indireta e ensaios de acessibilidade à proteínase K após 
solubilização com digitonina, concluindo-se que ambas as proteínas se encontram na 
mitocôndria, LimFRD na matriz e LiNDH2 associada com a membrana mitocondrial 
interna. Seguidamente, foram avaliados os efeitos da sobre-expressão de cada uma 
das proteínas no metabolismo energético, e, para tal, foram realizados estudos de 
consumo de oxigénio utilizando as estirpes que sobre expressam cada uma das 
proteínas comparando o seu fenótipo com o observado na estirpe selvagem. Verificou-
se que a estirpe que sobre-expressa a proteína LiNDH2 possui um aumento do 
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consumo de oxigénio basal, registando-se, também, um aumento da atividade do 
complexo II e de enzimas que fornecem eletrões ao primeiro ponto de entrada de 
eletrões na cadeia respiratória (incluindo NDH2). Por outro lado, verificou-se que a 
atividade respiratória dos parasitas OE_LimFRD apresentava uma menor sensibilidade 
à inibição por KCN, inibidor do complexo IV, o que sugere um maior consumo de 
oxigénio, para a produção de ROS pela LimFRD. Em relação ao consumo de oxigénio 
basal verificou-se que a estirpe wt e a OE_LimFRD apresentavam um comportamento 
semelhante. Foi também avaliado o efeito inibitório da rotenona, inibidor do complexo 
I, concluindo-se que este não possui efeito sobre as estirpes estudadas. 
Adicionalmente verificou-se que o efeito dos inibidores da fosforilação oxidativa no 
crescimento das 3 estirpes em análise wt, OE_LimFRD e OE_LiNDH2 é semelhante. 
De realçar a inibição de crescimento quase total obtida na presença de SHAM, um 
inibidor específico da oxidase alternativa. Conclui-se que é necessária a realização de 
mais estudos para perceber qual o papel de LimFRD e LiNDH2 no metabolismo 
mitocondrial destes parasitas, e, para tal, a criação de estirpes mutantes para LimFRD 
e LiNDH2, assim como a determinação da localização exata de LiNDH2 são etapas 
necessárias. 
 
 
 
 
 
 
 
 
Palavras-chave: NADH desidrogenase alternativa; fumarato reductase; oxidação de 
NADH; mitocôndria; Leishmania. 
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Leishmania spp. and Trypanosoma belong to the Trypanosomatidae family, a 
large group of flagellated parasitic protozoa that are responsible for diseases in 
humans and animals. Leishmania is responsible for causing different forms of 
leishmaniasis, the majority in tropical and subtropical regions. On the other hand, 
Trypanosoma spp cause chagas disease in Latin America (Trypanosoma cruzi) and 
human sleeping sickness in Africa (Trypanosoma brucei).  
Diseases caused by Leishmania and Trypanosoma currently affect about 22 
million people worldwide, and are considered the most important neglected tropical 
diseases. These parasites have a complex life cycle, alternating between vertebrate 
and invertebrate hosts. Studies of Trypanosomatidae family are now more rapid and 
efficient upon sequencing of the genome of several of these parasites. 
 
 1.1 Leishmania spp. 
The protozoan parasite of the genus Leishmania belongs to the 
Trypanosomatidae family and is the causative agent of leishmaniasis (1). The genus 
Leishmania comprises thirty species of which about twenty are pathogenic to humans 
(2,3). These parasites are responsible for one of the six most common parasitic 
infections in tropical regions (4) and its impact on public health is increasing due to the 
rapid expansion of endemic zones caused, in part, by the increase in global travel (5). 
This protozoan is responsible for the infection of twelve million people with 
leishmaniasis, resulting in more than 50.000 deaths each year (3,6,7).  
 
1.1.1 Leishmaniasis 
  Leishmaniasis is a major and increasing public health problem and comprises a 
large spectrum of diseases. Inside this spectrum we highlight three general 
classifications of human leishmaniasis: Cutaneous Leishmaniasis (CL), 
Mucocutaneous Leishmaniasis (MCL) and Visceral Leishmaniasis (VL), also known as 
kala-azar. The different types of leishmaniasis have distinct clinic manifestations, for 
instance, VL causes splenomegaly and hepatomegaly and is fatal if not treated (4). 
This disease caused by L. donovani and L. infantum (also designated as L. chagasi in 
South America) represents 90% of the cases registered in the world, being the most 
affected countries Bangladesh, India, Nepal, Sudan, and Brazil (8). Cutaneous 
leishmaniasis are localized, self-curing and caused by L. mexicana or L. braziliensis 
(1,9). Lastly, MCL lesions can partially or totally destroy the mucous membranes of the  
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nose, mouth, throat cavities and surrounding tissues and can be caused by different 
species of Leishmania such as L. braziliensis, L. guyanensis and L. aethiopica (1). The 
different clinical manifestations are due to differences between parasite species, host 
genetics and immunity factors (2). 
 
1.1.2 Life cycle 
Leishmania parasites are pathogens with a complex digenetic life cycle (10). 
During their life cycle, they shift between mammalian (amastigotes) and insect hosts 
(promastigotes).  In the promastigote form, parasites live within the digestive tract of 
the sandfly vector where they are elongated and possess a long flagellum, important 
for its motility and attachment to the sandfly gut (10). Furthermore the so-called 
promastigote form can include, different stages: procyclic, upon amastigotes return to 
the promastigote form and metacyclic, representatives of the infective stage (1). In the 
intracellular amastigote form, parasites live in parasitophorous vacuoles within 
macrophages (mammalian host); Amastigotes are characterized by its ovoid form and 
short flagellum that extends to the neck of the flagellar pocket (10,11). Amastigotes 
proliferate by binary cell division and can spread to other macrophages as well as 
some to other phagocytic cells (dendritic cells) or even no professional phagocytic cells 
(fibroblasts) (12). However, it is known that macrophages are the major host cells 
infected by these parasites (3). Amastigotes are responsible for acute infection, as well 
as, long term latent infections that can lead to reactivation of the disease years or 
decades after the primary infections, particularly in immunocompromised individuals 
(13).  
During the life cycle of the parasites, they must adapt to the different 
environments encountered. These environmental changes lead to a morphological 
alteration and to a drastic metabolic shift in the parasites. In the transition between the 
extra- and intracellular environments, the parasite is exposed to alterations such as, 
elevated temperature, toxic oxidants produced during phagocytosis, acidic pH and 
proteases encountered in the macrophage phagolysosomes (14). The cycle begins 
when the mammalian host is infected by flagellated promastigotes that are found within 
the digestive tract of the sandfly vector. This form of the parasites is transmitted to the 
mammalian host when a female sandfly injects the parasites into the skin, during its 
bite. The parasites are rapidly phagocytosed by neutrophils and macrophages, which 
possess on their surface several glycoconjugates that lead to adherence of 
promastigotes, and consequently trigger the phagocytic process (15). After 
phagocytosis, the parasites remain inside the parasitophorous vacuole and develop 
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into amastigotes. For this, the flagellated promastigotes have to differentiate into 
amastigotes that are able to live in the acidic pH habitat of the parasitophorous.  
 
 
 
 
Figure 1. Life cycle of Leishmania spp. The numbers shown in figure indicate the different steps in life cycle of the 
parasite. 1. Promastigotes are injected and phagocytosed by macrophages. 2. Promastigotes become amastigotes 
inside macrophages. 3. Amastigotes multiply within macrophages in various tissues. 4. Amastigotes differentiate into 
promastigotes in the midgut. 5. Promastigotes multiply in the midgut and migrate to proboscis.  
 
Then, macrophage lysis occurs caused by a large number of amastigotes 
resulting from multiple divisions. These free parasites can infect new macrophages or 
be ingested by sandflies during new blood meals. In sandflies, parasites enter into a 
differentiation process, where amastigotes transform into procyclic promastigotes, a 
process known as metacyclogenesis (Figure 1). Upon this, a new infection cycle starts 
with the differentiation of the non-infective forms into infective metacyclic promastigotes 
that migrate to the proboscis (1).  
Leishmania parasites are auxotrophic or have limited capacity to synthesize de 
novo a wide range of amino acids, purines, vitamins, lipids and other metabolites that  
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must, therefore, be available within the parasitophorous vacuole at sufficient levels to 
permit amastigote growth (3,16,17). Furthermore, the parasites have special organelles 
that either are absent in eukaryotic organisms, p.e. glycosomes, or have  different 
metabolic pathways (1). 
 
1.2 Carbon metabolism 
The study of trypanosomatids carbon metabolism requires a large 
comprehension about all possible metabolic pathways. The central carbon metabolism 
of these parasites is necessary for growth, defense against oxidative stress and other 
host microbicide responses. Alterations, even that partial, may be sufficient to 
destabilize the synthesis of metabolites essential for viability of the parasite (17). 
Trypanosomatids metabolic needs depend partially, if not completely, on the 
available carbon sources present in their hosts (18). Moreover, these parasites 
possess distinct characteristics in their metabolism. For instance, the glycolytic 
pathway is performed in a compartmentalized organelle, the glycosome, unlike in other 
organisms where glycolysis is accomplished in the cytoplasm (1,19). Furthermore, 
metabolic alterations between different species and along the life cycle of the parasites 
also occur (19). For instance, Leishmania within the mammalian host live in a habitat 
with complex nutrient composition due to constitutive internalization of macromolecules 
and their degradation by lysosomal proteases, lipases and glycosidases. In 
amastigotes, fatty acids are the main carbon sources used (13) opposing to 
promastigotes where glycolysis is the main metabolic pathway, thus showing the high 
adaptation of the parasites to the particular environments (20). Curiously, it was 
observed that in Leishmania most enzymes involved in central carbon metabolism, are 
constitutively express including those required for the catabolism of glucose, amino 
acids and fatty acids, even when the carbon sources are limited (13). 
The capacity of parasites to adapt to their energetic resources is an advantage 
for their stability and survival, as demonstrated in the following examples. In 
trypomastigote forms of T. brucei and T. cruzi, glucose is predominantly used because 
it is abundant in the fluids of the vertebrate host. Yet, the insect stage of T. brucei can 
use amino acid catabolism, with preference for L-proline, whereas T. cruzi also has the 
capacity to utilize D-proline in addition to L-proline (18). However, with the exception of 
Leishmania, glucose, when available, is the substrate selected for parasites growth, 
including for those forms in which glucose is not the natural carbon source. This 
routinely used carbon source to culture parasites culminated in a better knowledge 
about glucose metabolism in comparison to amino acid or fatty acid metabolism (18).  
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Understanding the way parasites produce ATP for their functioning and proliferation 
through the oxidation of carbohydrates, fatty acids or amino acids is of great relevance. 
 
1.2.1 Carbohydrates metabolism 
In trypanosomatids, glucose is degraded to pyruvate using the classical Emden-
Meyerhof pathway as in many other organisms (19,20). However, the first reactions of 
the glycolytic pathway are compartmentalized in modified peroxisomes termed 
glycosome (Figure 2). The maintenance of the glycosomal redox balance can be 
achieved either by the production of succinate or by the G3P/DHAP shuttle between 
glycosomes and mitochondria. The end product of glycolysis, pyruvate, enters the 
mitochondria and either is completely oxidized through the Krebs cycle or it is 
converted to acetate. Moreover, pyruvate can also be secreted after transamination to 
alanine, an essential biosynthetic precursor (18,21). 
The tricarboxylic acid cycle (TCA cycle) enzymes are expressed in 
trypanosomatids where they catalyze the oxidation of acetyl-CoA and are also involved 
in non-cyclic pathways such as the formation of citrate and succinate and the 
catabolism of amino acids (22). Studies in T. brucei suggest that this non-cyclic 
function is the main mode of operation of the TCA reactions (23).  
In all trypanosomatids, except for the long-slender bloodstream forms of T. 
brucei, glucose metabolism can result in acetate secretion, an end product generated 
by a two-enzyme cycle involving acetate:succinate CoA-transferase (ASCT) and 
succinyl-CoA synthetase that also produces adenosine triphosphate (ATP) by 
substrate level phosphorylation (Figure 2). 
The production of glucose by gluconeogenesis is essential for amastigotes 
virulence and their proliferation inside macrophages, in opposition with the 
promastigotes that can survive without this pathway (20). Glucose uptake in L. 
mexicana promastigotes was shown to be essential for macrophage infection as 
evidenced by studies in a mutant that lacks all the glucose transporters. This mutant 
fails to differentiate into amastigotes in vitro, and thus the hexose requirements in this 
stage are largely unknown (24). 
The capacity of trypanosomes to respond to differences in glucose availability 
was evaluated. Bloodstream trypanosomes when in a glucose-rich environment 
express a low affinity transporter with a high capacity for carbohydrate transport. On 
the other side, T. brucei and T. cruzi when in a low glucose environment express 
transporters with high affinity for glucose (25). Furthermore, T. brucei in glucose-
depleted or limited environment modify their metabolism by increasing L-proline 
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consumption (26). Leishmania and T. cruzi are also not dependent on glucose as these 
parasites have the ability to degrade amino acids in addition to glucose (19).   
 
1.2.2 Amino acid metabolism  
 Amino acids are also substrates used for energetic metabolism in parasites. In 
trypanosomatids, the catabolic pathways for many amino acids (glutamate, glutamine, 
threonine, proline and others) generate intermediates of the Krebs cycle (25,27) that 
can be completely oxidized or used as biosynthetic precursors in anabolic pathways 
(Figure 2). 
Procyclic T. brucei in glucose-depleted conditions uses proline or other amino 
acids that are catabolized by the TCA cycle. It is known that Leishmania promastigotes 
when in glucose limited conditions also use proline, however, it is not totally clear which 
catabolic pathway is involved in proline oxidation (6). Other amino acids are used for 
specific biosynthetic purposes rather than for energy metabolism. For example, 
arginine and leucine are used for polyamine and sterol/isoprenoid synthesis, 
respectively (19).  
The genome of Leishmania encodes a large number of putative amino acid 
permeases responsible for amino acid uptake and some of them are regulated in a 
stage-specific manner (28,29).  
 
1.2.3 Fatty acid metabolism 
Fatty acids are used as an alternative carbon source by various intracellular 
pathogens (3). Fatty acids are not considered an important substrate used in energy 
metabolism of trypanosomatids, however amastigotes of Leishmania and T. cruzi are 
exceptions. Thus, it was reported that L. mexicana amastigotes have an increase in 
fatty acid metabolism and a reduction in proline and glucose metabolism (19,20). 
Actually, β-oxidation appears to be negligible in rapidly dividing promastigotes but 
increased in non-dividing promastigotes and in axenic amastigotes. Moreover, 
enzymes involved in fatty acid oxidation are upregulated in L. donovani and L. major 
amastigotes (3). 
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Figure 2. Schematic representation of the metabolic pathways of energy metabolism of trypanosomatids. 
Adapted from (19). 
 
Phosphoenolpyruvate 
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1.3 Mitochondria 
Mitochondria are important organelles, where essential physiological processes 
occur, such as synthesis and catabolism of crucial amino acids, fatty acid oxidation, 
iron sulfur cluster biogenesis and oxidative phosphorylation (aerobic organisms)  
(OXPHOS) (30,31). Catabolic processes result in the production of NADH and occur 
mainly in the mitochondrial matrix. The NADH formed can be oxidized in the respiratory 
chain resulting in ATP production through oxidative phosphorylation, the main place 
where ATP is produced (32).  Beyond the metabolic processes, the mitochondrion is 
involved in other important cell processes, such as programmed cell death, oxidative 
stress generation and signaling (1).   
In trypanosomatids, the mitochondrion is a single and ramified organelle and 
occupies generally 12% of the protozoan volume (31). As for other organisms, 
trypanosomatids mitochondrion is constituted by an outer membrane, a dense matrix 
and an inner membrane that folds into thin and irregularly distributed cristae whose 
number broadly vary (30). The shape of the organelle varies according to the type of 
parasite and to its developmental stage (14,31). Moreover, the mitochondrion shape, 
extension and function changes in response to alterations in the environment thus 
showing its extreme dynamic capacity. An example often referred about alterations in 
mitochondrial metabolism, occurs in the electron respiratory chain (ERC) of T. brucei. 
The procyclic form has a complete TCA cycle and a fully functional canonical 
respiratory chain, while, in the bloodstream form the ERC is extremely different with 
simpler components involved. Indeed, some trypanosomatids use an alternative 
oxidase to remove excessive reducing equivalents, instead of the respiratory 
complexes III and IV. This enzyme is also found in fungi and plants (19). Moreover, 
ATP production in bloodstream forms occurs mainly by substrate level phosphorylation 
due to a high glycolytic flux (23). In fact, even in procyclic trypanosomatids growing in 
glucose-rich medium, mitochondrial ATP synthase has a minor role in ATP production 
(18). However, the activity of the OXPHOS plays a crucial role in the survival of 
Leishmania amastigotes and promastigotes (8,33).   
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Figure 3.  Schematic representation of the OXPHOS in Leishmania spp. I,II, III,IV and V refer to the OXPHOS 
complexes; Q- quinone; NDH2- alternative NADH dehydrogenase; mFRD- mitochondrial fumarate reductase; G3PDH- 
Glycerol-3-phosphate dehydrogenase. 
 
1.3.1 Electron Respiratory Chain    
The canonical electron respiratory chain of eukaryotes is localized in the 
mitochondrial inner membrane and in its constitution has four different multi-subunit 
enzymes, designated by respiratory complexes I-IV. NADH dehydrogenase (Complex 
I), Succinate dehydrogenase (Complex II), cytochrome c reductase (Complex III) and 
cytochrome c oxidase (Complex IV). These complexes transfer electrons from reduced 
co-factors produced by catabolic pathways (such as fatty acid oxidation, amino acids 
and citric acid cycle) to the final acceptor, oxygen. The process where oxygen is 
consumed is denominated as respiration (8).  
Complex I is the first enzyme of the mitochondrial respiratory chain, contains a 
non-covalently bound FMN molecule and eight iron-sulfur clusters (FeS), and is 
responsible for the transference of 2 electrons from NADH to ubiquinone (34). Complex 
II is the smallest respiratory complex and participates in both the TCA and the electron 
transport chain. This enzyme has covalently bound FAD as well as heme b and 
donates electrons to ubiquinone reducing it to ubiquinol. Complex III contains heme 
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and FeS clusters as co-factors and is responsible for the reduction of cytochrome c (cyt 
c) and oxidation of coenzyme Q. The last enzyme of the respiratory chain, complex IV, 
receives the electrons from cytochrome c and transfers them to oxygen. Complex I, III 
and IV use the energy of electron transfer to produce a proton gradient across the 
mitochondrial inner membrane that is then utilized by F1/F0 ATPase (Complex V) to 
produce ATP. Complex V along with the ERC constitutes the oxidative phosphorylation 
machinery (35). The canonical respiratory chain is sensitive to some inhibitors, such 
as, rotenone, thenoyltrifluoroacetone (TTFA), antimycin A and cyanide, inhibitors of 
complex I, II, III and IV, respectively (36).  
In trypanosomatids the exact constitution of the respiratory chain is unclear, 
although some evidences exist for the presence of canonical complexes and non-
canonical enzymes. In a recent study it was demonstrated that complexes II-IV are 
present and functional in procyclic T. brucei, T. cruzi, Crithidia and Leishmania spp 
(8,37). Phytomonas serpens lacks complexes III and IV and instead expresses an 
alternative oxidase, as the bloodstream form of T. brucei (35,38). Moreover, it was 
verified that some Leishmania spp required OXPHOS for survival in both promastigote 
and amastigote forms (8,39).  
The presence of complex I in trypanosomatids is still an issue that raises much 
doubt. It was reported that the complex I inhibitor rotenone has low specificity in 
trypanosomatids, where high concentrations are necessary for complex I inhibition 
(37,40). More recently, complex I was clearly identified in P. serpens and T. brucei 
while in L. tarentolae and C. fasciculata its presence was not confirmed (35). However, 
genome mining identifies many genes coding for complex I subunits in the genome of 
several Leishmania spp and C. fasciculata (41). The absence of canonical complex I in 
some trypanosomatids can be compensated by the presence of alternative enzymes 
able to oxidize NADH, namely alternative NADH dehydrogenase (NDH2) and fumarate 
reductase (mFRD) (41). 
 
1.3.1.1 Alternative NADH dehydrogenase  
The alternative NADH dehydrogenase (NDH2), the so-called rotenone 
insensitive NADH dehydrogenase, is a single polypeptide chain and contains a non-
covalently bound molecule of FAD as cofactor (42,43). These enzymes are 
characterized by the absence of a transmembrane domain and the presence of two 
conserved GxGxxG motifs (44). The crystallographic structure of a yeast alternative 
NADH dehydrogenase shows that it is a monotopic protein interacting with the inner 
mitochondrial membrane by the C-terminal domain (34). This carboxy-terminal domain 
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is also critical for the catalytic activity of the enzyme (45). As a monotopic protein, 
NDH2 can interact with either the external or the internal surfaces of the inner 
mitochondrial membrane (46), and thus, catalyze the transfer of electrons from the 
cytosol (external) or matrix (internal) NAD(P)H into the mitochondrial pool of 
ubiquinone. This electron transfer reaction occurs without proton translocation across 
the inner membrane, meaning that NDH2 is not associated with the generation of a 
proton electrochemical gradient, unlike complex I (47).    
NDH2 was first identified in plants (48), and then was found in bacteria (49), 
fungi (50,51) and parasites (52) but its function, in most cases, is not completely 
understood.  Differences in the number and orientation of NDH2 are verified in some 
organisms where up to five NDH2 enzymes can be present in both the external and the 
internal faces of the inner mitochondrial membrane (16,43). This enzyme has been 
extensively studied in various organism namely, Neurospora crassa (50,51), Solanum 
tuberosum (53), Saccharomyces cerevisiae (54) and Mycobacterium tuberculosis (49).  
The filamentous fungus N. crassa contains one internal and two external alternatives 
NADH dehydrogenases in addition to complex I (50). Inhibition of both complex I and 
the internal alternative NADH dehydrogenase is lethal for the fungus. However, when 
only one is absent the organism survives, meaning that the internal NDH2 has a 
complementary function to complex I in N. crassa (50). Furthermore, yeasts also 
possess alternative NADH dehydrogenases where they can co-exist with (Yarrowia 
lipolytica) or without (S. cerevisiae) complex I. S. cerevisiae possess three alternative 
dehydrogenases, one internal (NDI1) and two external (NDE1 and NDE2). NDI1 has 
been suggested to play a role in regulating the redox balance at the level of 
mitochondrial NADH produced by the citric acid cycle (55), and the external alternative 
dehydrogenases have an important role in the re-oxidation of the cytosolic NADH 
produced by glycolysis (56). Y. lipolytica contains only one alternative NDH2 enzyme 
located of the external side in the inner mitochondrial membrane.  Complex I in Y. 
lipolytica is essential since the external NDH2 cannot oxidize matrix NADH and thus, 
compensate for complex I (57). Deletion of the alternative NDH2 did not affect viability 
or growth rate revealing a non essential role of this enzyme in this yeast (42).  
In many protozoa parasites the entry of electrons from NADH into the 
respiratory chain is made by NDH2 instead of the canonical complex I. Plasmodium 
falciparum expresses one alternative NDH2 (58) and Toxoplasma gondii expresses two 
internal NDH2 enzymes (59). Moreover, a NDH2 enzyme was also identified in T. 
brucei (60) with orthologous proteins predicted in many other trypanosomatids. 
Depletion of NDH2 in procyclic T. brucei decreases the mitochondrial membrane 
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potential and leads to a significant increase in the activity of G3PDH (61). This 
phenotype of the knockdown strain allowed the authors to conclude that T. brucei 
NDH2 is a intermembrane space facing enzyme, oxidizing cytosolic NADH (61). 
M. tuberculosis and M. smegmatis are examples where alternative 
dehydrogenases have an essential role in growth even in the presence of complex I. 
Some evidences suggest that NDH2 have an important role in bacteria that 
preferentially use a non-proton pumping NDH2 instead of the proton-pumping NDH1 
when both enzymes are present. The relevance of NDH2 in these bacteria is probably 
associated with the fact that it is not inhibited by a high proton motive force as is 
complex I, which could ultimately slow down the metabolic flux due to back-pressure on 
the system (16). 
Alternative NADH dehydrogenases are seen as promising therapeutic targets 
due to their essential role in many bacterial and eukaryotic pathogens and to their 
absence in mammalian mitochondria (16,41).  
 
1.3.1.2 NADH-dependent fumarate reductase  
The enzyme NADH-fumarate reductase catalyzes the reduction of fumarate, 
generating succinate, in the presence of NADH (22,62). Multiple forms of fumarate 
reductases are present in prokaryotes and eukaryotes and they include membrane-
bound and soluble proteins (32). The membrane associated enzymes are multi-subunit 
complexes that performed the reverse reaction of succinate dehydrogenase. The 
trypanosomatid enzyme is a single polypeptide that uses NADH to reduce fumarate 
either in the mitochondrion or in glycosomes. These enzymes were characterized in T. 
brucei procyclic forms and orthologues were identified in the genome of T. cruzi and 
Leishmania spp (62). The mitochondrial enzyme produces succinate as a final product 
that can be used by the respiratory chain (complex II) or be excreted into the medium 
(32,42).  FRDs are multifunctional proteins with three different domains, an ApbE 
domain, a fumarate reductase domain and a cytochrome b5 reductase domain (22,41). 
Virginie Cousteau and colleagues described three FRD isoforms in T. brucei 
where two of them are putative mitochondrial proteins and the other is glycosomal. 
Expression of the proteins was confirmed by western blotting although one of the 
mitochondrial isoforms is probably not expressed. It was also seen that knockdown of 
mFRD, but not of gFRD, resulted in a significant cell death at the beginning of the 
culture. However, after 2-3 days under the induction conditions no cell mortality was 
observed, suggesting an adaptive compensation of the reduced mFRD expression. The 
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relevance of these enzymes is recognized when the constitutive knockdown of mFRD 
or both isoforms failed, indicating an important role of mFRD in the parasite (22). 
Moreover, T. brucei mFRD was associated with an intracellular production of 
reactive oxygen species in the absence of fumarate (32). This enzyme is regarded as a 
promising therapeutic target, since it is absent in mammalian cells. Furthermore, 
studies with inhibitors of fumarate reductase demonstrate that its inhibition is lethal for 
trypanosomatids, revealing the importance of this enzyme (32,63). 
 
1.4. Drug Development 
Leishmaniasis is a worrying disease owing to the number of people affected 
and to the fact that no efficient drugs exist. Recently about 25 compounds and 
formulations were described for the treatment of leishmaniasis (5), however, these 
drugs continue to have, low efficacy, high toxicity, high expenses and frequently 
widespread resistance (2). Taking into account the increase number of deaths by 
leishmaniasis it is urgent the development of novel drugs, for old or new parasite 
targets, to overcome the parasite multidrug resistance. Searching for new 
antileishmanial drug targets, we have focused our studies on the electron respiratory 
chain of L. infantum mitochondria (14). Both NDH2 and mFRD are proteins absent in 
mammalian mitochondria with important roles in the parasite, suggesting that they can 
be potential drug targets. 
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Leishmaniasis is a neglected disease caused by Leishmania spp. and despite 
the ongoing investigations to find an efficient drug against the disease, a cure is still not 
available. Current treatments are limited and present several side effects, underlining 
the importance of developing new drugs. Given that LimFRD and LiNDH2 proteins are 
absent from mammalian mitochondria, these enzymes can be seen as potential drug 
targets. Thus, this study aims at understanding the involvement of these two NADH 
oxidizing enzymes, LimFRD and LiNDH2, in mitochondrial metabolism of Leishmania 
infantum. To accomplish this goal and thoroughly characterize both enzymes, we:  
 
1) Produced specific antibodies against LimFRD and LiNDH2 proteins, using 
as antigens the recombinant proteins expressed and purified from 
Escherichia coli; 
 
2) Determined the subcellular localization of both proteins in order to elucidate 
which NADH pool (cytosolic or matrix) is the substrate for these enzymes; 
 
3) Pursued the characterization of the overexpressing strains, OE_LimFRD 
and OE_LiNDH2, in terms of respiratory chain alterations induced by the 
increased expression of either LimFRD or LiNDH2. Moreover, the effect of 
OXPHOS inhibitors on growth of OE_LimFRD and OE_LiNDH2 strains, 
compared to wild type growth, was evaluated. We expected to identify the 
metabolic pathways affected by overexpressing either LimFRD or LiNDH2. 
 
 
 
 
 
 
 
 
FCUP/ICBAS 
Study of alternative NADH dehydrogenase and mitochondrial fumarate reductase in Leishmania Infantum 
17 
 
 
 
 
 
 
Materials and Methods 
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3.1 Bioinformatics analysis 
Genome sequence of LinJ.36.5620 and LinJ.35.0850 for L. infantum NADH 
dehydrogenase (LiNDH2) and L. infantum mitochondrial fumarate reductase (LimFRD) 
respectively were obtained at the Kinetoplastid Genome Resource: TriTrypDB. Amino 
acid sequences alignment was carried out with the BLAST software. 
 
3.2 Construction of the recombinant vectors 6HisLimFRD and 
6HisLiNDH2  
For the construction of pET28_6HisLimFRD and pET28_6HisLiNDH2, LimFRD 
and LiNDH2 open reading frames (ORF) were amplified with Pfu Turbo DNA 
polymerase (Stratagene) using primers described in table 1.  
 
Table 1. Primer sequences used for LimFRD and LiNDH2 ORF amplification.  Restriction sites are underlined in the 
sequences and clamp sequences are in lowercase. 
 
PCR products obtained for LimFRD and LiNDH2 were cloned, respectively, between 
NdeI/HindIII and NdeI/XhoI restriction sites of the pET28 expression vector (Novagen) 
in frame with a N-terminal 6His-tag. pET28_6HisLimFRD and pET28_6HisLiNDH2 
plasmids were transformed into Escherichia coli DH5α strain competent cells and 
plasmid DNA was extracted using Genelute plasmid miniprep kit (Sigma Aldrich). For 
fusion protein expression, each of the plasmids was introduced into E.coli BL2I, 
BL21CodonPlus and Rosetta competent cells. Correct DNA sequence was confirmed 
by sequencing analysis. 
  
 
Primer LimFRD LiNDH2 
Forward 
5´ccgcgcaCATATGGCCACCG
CGAGCTTCGTGA-3´ 
5´ccgcgcaCATATGCTGCGCAGCAC 
GTTGCG-3´ 
Reverse 
5´gggAAGCTTGAGTCATTTG
GCCGACTGC-3´ 
5´-caccgCTCGAGCTACATTTTCTTTTC 
GGGTTC-3´ 
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3.3 Bacterial protein extracts preparation and polyacrylamide 
gel analysis  
E. coli BL2I, BL21CodonPlus and Rosetta with plasmid pET28_6HisLimFRD or 
pET28_6HisLiNDH2 were grown overnight in Luria broth media (LB) supplemented 
with kanamycin (50 µg ml-1) at 200 rpm, 37ºC. After this, bacteria were diluted 1.5:100 
in LB and grown at 37ºC and 150 rpm until 0.5-0.9 Optical Density at 600nm (OD600). 
Then, protein expression was induced with 0, 0.1, 0.25 or 0.5 mM isopropyl-β-D-
galactopyranoside (IPTG), at 25ºC during 5 hours. Protein extracts from 3 ml bacterial 
culture were obtained by pelleting (775g , 10 min) and further processing by sonication 
using a Branson sonifier (5x10 seconds on ice). Lysates were then centrifuged 
(16873g, 10 min) in order to fractionate the samples. Afterwards, supernatant (soluble) 
and pellet (membrane plus insoluble) fractions were resuspended in gel Loading Buffer 
(50 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 0.1% (w/v) bromophenol blue, 10% (w/v) 
glycerol and 2% (v/v) β-mercaptoethanol) (GLB) and boiled for 10 minutes at 95 ºC. 
The different fractions were loaded into a 10% SDS-PAGE gel and after running was 
completed the gel was stained with coomassie blue (0.1% Coomassie Blue R250 in 
10% (v/v) acetic acid, 50% (v/v) ethanol). 
 
3.4 Large scale expression of His6LimFRD and His6LiNDH2 
proteins  
His6LimFRD and His6LiNDH2 proteins were induced as described above in 500 
ml culture. Subsequently, bacteria were centrifuged for 20 min at 9150g, 4ºC. Collected 
pellets were washed once and resuspended in phosphate buffered saline (PBS), 
always on ice. The resulting suspension was sonicated (5x10 seconds on ice) and 
centrifuged, for 30 minutes at 26700g, 4ºC. Aliquots of pellets and supernatant 
fractions were resuspended in GLB and boiled for 10 minutes at 95 ºC and loaded into 
a 10% SDS-PAGE gel that was stained with coomassie blue to check for protein 
expression.  
 
 
 
 
 
FCUP/ICBAS 
Study of alternative NADH dehydrogenase and mitochondrial fumarate reductase in Leishmania Infantum 
20 
 
3.5 Purification of His6LimFRD and His6LiNDH2 proteins 
 
3.5.1 Metal ion affinity chromatography  
Fresh induced bacterial pellets were resuspended in Buffer A (20 mM Tris-HCl, 
500 mM NaCl, 5mM imidazole, pH 7.6), sonicated (10x10 seconds on ice) and then 
centrifuged for 20 min at 26700g, 4ºC. The supernatant was loaded into a Histidine 
Bind resin (HiTrap, GE Biosciences) column, previously equilibrated with Buffer A 
without imidazole. Alternatively, the pellet was solubilized with Buffer A+8 M urea for 1 
h at room temperature (RT), centrifuged as described above and the supernatant was 
applied into a Histidine Bind resin equilibrated with Buffer A+8 M urea. The collected 
flow through was reloaded at a flow rate of 1.5 ml min-1 in order to improve the 
purification yield.  Elution was carried out by a linear imidazole gradient through 
increased Buffer B (20 mM Tris, 0.5 M NaCl and 1 M imidazole). Furthermore, several 
purification conditions were evaluated by adding different compounds, namely SDS, 
urea, Triton X-100 and dithiothreitol (DTT) to both Buffers A and B in order to improve 
the process efficiency.  
 
3.5.2 Preparative gel  
For this procedure, fresh induced bacterial samples were prepared. 
His6LimFRD and His6LiNDH2 expressed in E.coli inclusion bodies were washed with 2 
M urea followed by a 3 M urea wash in Buffer A and then solubilized with 8 M urea for 
1h at RT. Supernatants of 8 M urea incubation were precipitated with 20% (w/v) 
trichloroacetic acid, incubated 20 minutes on ice and centrifuged for 10 minutes at 
16873g, 4ºC. Pellets were washed with acetone, vortexed and immediately centrifuged 
as previously described. Precipitates were dried at RT, resuspended in loading buffer ( 
50 mM Tris pH 8.8, 2% SDS (w/v), 10% glycerol, 2 mM EDTA, 0.02% (w/v) 
bromophenol blue, 5% (w/v) DTT) and heated at 65ºC for 10 min. Processed samples 
were then loaded into a 15 % polyacrylamide gel (30% acrylamide/bis acrylamide 
(37.5:1); 1.875 M Tris-HCl pH 8.8;  10% SDS (w/v); Temed; 10% APS (w/v)) and run 
with the specific buffers: upper buffer (1.5 mM Tris; 9.4 mM glycine; 0.1% SDS; 0.12 
mg/ml coomassie R250) and lower buffer (1.5 mM Tris; 9.4 mM glycine; 0.1% SDS) at 
30 mA for 4 hours.  
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After gel running, the selected bands were excised from the stained gel with a 
blade, crushed with a syringe and incubated overnight in 20 ml of 0.02% SDS, 5 mM 
DTT solution. After protein extraction, suspension was centrifuged and the resulting 
supernatant was collected and rapidly frozen with a mixture of dry ice and 70% ethanol. 
The resulting samples were lyophilized to reduce volume and then precipitated with 80-
90% acetone and incubated overnight at -20ºC. After this, samples were centrifuged 
and the pellets resuspended in PBS. This material was sent to animal facility (IBMC) 
for rat immunization. 
 
3.6 Parasite culture  
          Leishmania infantum promastigotes derived from the MHOM/MA/67/ITMAP-263 
were cultured at 26ºC (BK 4062, EHRET) in RPMI 1640 medium with glutaMAX 
(Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBSi, 
Invitrogen), 20 mM HEPES sodium salt buffer (Sigma) pH 7.4, 50 U ml−1 penicillin and 
50 µg ml−1 streptomycin (Gibco). The transfected L. infantum promastigotes were 
cultured in the presence of 15 µg ml-1 Geneticin (G418). 
 
3.7 Parasite protein extracts and western blot analysis 
 Protein extracts were prepared from cultures of L. infantum promastigotes and 
axenic amastigotes. Initially, 5x106 cells were pelleted by centrifugation for 10 min at 
3000 rpm, washed with PBS and lysed with 8 µl 50 mM Tris-HCl pH 7.6, 4% SDS 
solution, then 10 µl PBS and 5 µl 5xGLB were added. Cells were then gently vortexed, 
incubated for 10 minutes at 65 ºC and loaded into a 10% SDS-PAGE gel. Afterwards, 
the proteins were transferred onto a nitrocellulose Hybond-C Extra membrane (GE 
Biosciences), the membrane was incubated in a blocking solution of 5% skim milk in 
TBS-T (20 mM Tris-HCl, 137 mM NaCl, 0.1% Tween 20, pH 7.6) during 1 hour, 
followed by incubation with primary antibodies (shown in table 2). Membranes were 
then washed 3 times 5 minutes each with TBS-T and incubated with secondary 
antibodies for 1 hour. After washing as described above, membranes were revealed 
using Claritytm western ECL substrate (BIO-RAD) chemiluminescence kit to detect the 
bands. The images were acquired using image lab software (Biorad). 
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Table 2. List of primary and respective secondary antibodies used for western blotting analyses. 
 
 
 
 
 
 
 
 
 
3.8 Immunofluorescence  
L. infantum promastigotes were collected and washed once with PBS. Parasites 
were fixed during 10 minutes in 4% (w/v) formaldehyde in PBS at RT and then 
centrifuged for 5 min at 775g, 4ºC. Pellets were washed, ressuspended in PBS and 
placed onto polylysine slides previously smeared. Parasites were left to dry for 15-20 
minutes at 45ºC, rehydrated with PBS and incubated with 0.1 M glycine in PBS for 15 
minutes at RT.  After this, cells were permeabilized with 0.05 M glycine, 0.1% (w/v) 
Triton X-100 in PBS for 8-9 minutes at RT, followed by several washes with PBS. 
Then, cells were blocked for 30-60 minutes with 1% (w/v) bovine serum albumin (BSA) 
at RT, and incubated in a humid chamber with the primary antibody (shown in table 3) 
for 1 hour at RT. Afterwards, the slides were washed and then incubated in a humid 
dark chamber with the respective secondary antibody during 1 hour at RT. The excess 
secondary antibody was removed with PBS and cells were incubated with 5 µg ml-1, 
4',6-diamidino-2-phenylindole (DAPI) for 15 min. Slides were immediately mounted with 
60% glycerol and visualized in a Zeiss Axio Imager Z1 microscope (Carl Zeiss). Images 
were acquired using the AxioVision Rel. 4.8 software (Carl Zeiss). 
 
 
 
 
 
 
 
Primary antibody Secondary antibody 
α- LiNDH2 (1:1000) 
α- rat(1:4000) α- LimFRD (1:1000) 
α- LiZIP1(1:1000) 
α- cMyc (1:100) α- mouse (1:5000) 
α- mTPX (1:1000) 
α- rabbit(1:10000) 
α- GAPDH  (1:1000) 
α- LiTryS  (1:1000) 
α- arginase  (1:100) 
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Table 3. List of primary and respective secondary antibodies used for immunofluorescence analyses. 
 
 
 
 
 
3.9 Alkaline carbonate extraction of membrane proteins 
Logarithmically growing cells were harvested, washed twice with PBS and 
resuspended in a freshly made 0.1 M Na2CO3 pH 7.4 solution at final concentration 
1x108 parasites ml-1. After this, cells were disrupted by sonication (10x10 seconds on 
ice) and incubated for 20 minutes on ice. After incubation, the suspension was 
centrifuged (Optimaltm L-80 XP ultracentrifuge, Beckman Coulter) for 75 minutes at 
100.000g, 4ºC. The pellet was resuspended in GLB and the supernatant was incubated 
during 30 minutes with 10% trichloroacetic acid on ice. After precipitation, the 
supernatant was centrifuged for 15 minutes at 16873g, 4ºC. The resulting pellet was 
washed with acetone, centrifuged as described above, dried and resuspended in GLB.  
 
3.10 Digitonin /proteinase assay  
Three days culture (logarithmic culture) parasites were centrifuged at 775g for 
10 min at RT. The pellet was washed twice with PBS and resuspended in digitonin 
(DIG) buffer (25 mM Tris-HCl, pH 7.8; 1 mM EDTA; 0.6 M sucrose; 1 mM E-64; 5 mM 
pepstatin; 1mM PMSF) at a final concentration of 2x109 parasites ml-1. Equal volumes 
of parasites (1x107) were incubated on ice for 3 minutes with different digitonin 
concentrations 0, 0.0625, 0.25, 0.75, 1.0, 1.5 and 2.5 mg per mg of protein. Then, 15 
volumes of DIG buffer were added to each sample in order to stop membrane 
solubilization. After this, 30 µg ml-1 of proteinase K (PK) were added and incubated 
during 20 minutes on ice.  The PK reaction was terminated by addition of 2 mM 
phenylmethylsulfonyl fluoride (PMSF), during 5 minutes on ice.  Then, samples were 
precipitated with 10% (w/v) trichloroacetic acid, incubated for 30 minutes on ice and 
centrifuged for 10 minutes, at 16873g, 4ºC. The pellet was washed with acetone, dried 
Primary antibody Secondary antibody 
α- LiNDH2 (1:500) Alexa Fluor 488 α-rat (1:2000) 
α- LimFRD (1:500) Alexa Fluor 488 α-rat (1:2000) 
α- mTPX (1:1000) Alexa Fluor 468 α-rabbit (1:2000) 
α- cMyc  (1:100) Alexa Fluor 488 α-mouse (1:2000) 
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at RT and resuspended in GLB with 5% β-mercaptoethanol. The protein fractions were 
analyzed by western blot.  
 
3.11 Enzymatic assays 
3.11.1 Bacterial membrane preparations  
Bacteria expressing either His6LimFRD or His6LiNDH2 were centrifuged for 20 
minutes at 9150g, 4ºC and the pellet was resuspended in solution 1 (50 mM Tris-HCl 
pH 8.0, 1 mM EDTA, 1 mM PMSF). Suspension of bacteria was disrupted by cell 
cracker emulsiflex C5 (Avestin) and centrifuged for 25 min at 26700g, 4ºC. The 
supernatant was centrifuged (Optimaltm L-80 XP ultracentrifuge, Beckman Coulter ) for 
75 minutes, 100.000g at 4ºC and the resulting pellet resuspended in solution 2 (50 mM 
Tris-HCl pH 8.0, 1 mM EDTA, 200 mM NaCl, 1 mM PMSF and 10% glycerol). 
Membranes were homogenized and protein concentration was determined using 
Pier(R) BCA Protein Assay (Thermo scientific). 
 
3.11.2 Parasite membranes preparation 
 Logarithmic parasites (1x108) were pelleted and washed with PBS. 
Subsequently, pellets were resuspended in 500 µl 1xSoTE (20 mM Tris-HCl pH 7.5, 
0.6 M sorbitol, 2 mM EDTA) and 500 µl 0.06% (w/v) DIG in 1xSoTE were gently added. 
The tubes were inverted 2 times and incubated on ice during 5 minutes. Then, samples 
were centrifuged for 5 minutes at 5510g (Eppendorf, Centrifuge 5418), 4ºC. Pellet was 
washed with SoTE (without resuspension) and centrifuged, as mentioned above. 
Lastly, pellet was carefully resuspended in 200 µl 1x SoTE. 
 
 
3.11.3 Enzymatic assays for NADH:Q1 oxidoreductase and fumarate reductase 
 
Table 4. Enzymatic assays composition. 
NADH:Q
1
 NADH:Fumarate 
1.5 ml 50 mM KPP pH 7.1 
1 mM KCN 
250 µM  NADH 
60 µM Q1 1 mM Fumarate 
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The consumption of NADH was measured at 340 nm, at 25ºC or 37ºC using a 
spectrophotometer Shimadzu UV-2041 PC. The reaction was monitored during 300 
seconds.  
3.12 Oxygen Consumption 
L. infantum promastigotes cultured at 1.4-2.0 x107 parasites ml-1 were 
centrifuged, washed with PBS and resuspended to a final concentration of 2x108 ml-1. 
Oxygen uptake with intact parasites was measured polarographically at RT with a 
Clark-type oxygen electrode (Hansatech). The assays started with the addition of 0.10-
0.4 mg (1.5-6 x x107 parasites) of protein to the reaction medium containing 0.3 M 
sucrose, 10 mM potassium phosphate pH 7.2, 5 mM MgCl2, 1 mM EGTA, 10 mM KCl, 
4 μM carbonyl cyanide m-chlorophenylhydrazone (CCCP), and 0.02% (w/v) BSA. 
During the assay, different substrates and inhibitors were added to the reaction. The 
substrates used were 5 mM succinate or 3 mM L-proline and the inhibitors were 2 mM 
TTFA, 60 µM rotenone and 1 mM KCN. Results were evaluated with O2view software 
(Hansatech). 
 
 
3.13 Effects of inhibitors on L. infantum promastigotes growth 
Parasites at 1x106 ml-1 final concentration were inoculated in 24- well plates 
with RPMI in the presence of different respiratory chain inhibitors. The plate was 
incubated for 3 days at 26 ºC. The concentrations of the inhibitors tested were 1 mM 
for KCN, 20 and 60 µM for rotenone, 2 mM for TTFA, 2 µg ml-1 for antimycin, and 2 µg 
ml-1 for oligomycin and 0.5, 1.0 and 5.0 mM for Salicylhydroxamic acid (SHAM). 
Afterwards, growth was monitored through microscope visualization. The final result of 
inhibition was evaluated by measuring OD600nm using a spectrophotometry (UV-VIS 
spectrophotometer, Shimadzu). 
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In this work we investigate two proteins involved in mitochondrial metabolism of 
Leishmania infantum, namely: mitochondrial fumarate reductase (LimFRD) and the 
alternative NADH dehydrogenase (LiNDH2). The amino acid sequences of LimFRD 
and LiNDH2 (LinJ.35.0850 and LinJ.36.5620, respectively) were obtained from the 
Kinetoplastid Genome Resource: TriTrypDB. LimFRD and LiNDH2 encode proteins 
with a theoretical molecular weight of 129.7 and 57.5 kDa, respectively.  These 
proteins are highly homologous to proteins present in other organisms belonging to the 
Trypanosomatidae family, as shown in table 5.  
 
Table 5. Homology between LimFRD and LiNDH2 and its respective orthologous proteins from 
trypanosomatids. The percentage of identity was determined upon alignments performed with BLAST software using 
sequences obtained from TriTrypDB database. The access number of the proteins used is: XP_003864671.1, 
XP_003879080.1, EKF32293.1, XP_822614.1 and CCW64868.1 for LimFRD homologues and XP_003865675.1, 
XP_003874897.1, EKG04215.1, XP_823167.1 and CCW63333.1 for LiNDH2 homologues, from L. donovani, L. 
mexicana, T. cruzi, T. brucei and Phytomonas, respectively.  
 L. donovani L. mexicana T. cruzi T. brucei Phytomonas 
LimFRD 99 95 63 60 52 
LiNDH2 99 97 62 62 65 
 
4.1 Expression and purification of His6LimFRD and His6LiNDH2 
proteins  
Expression and purification of His6LimFRD and His6LiNDH2 proteins was 
performed in order to produce antibodies against these polypeptides. To accomplish 
this objective we started with the production in large scale of the two proteins. For this 
purpose, LimFRD and LiNDH2 ORF were separately cloned into pET28 expression 
vector, generating, pET28_6HisLimFRD and pET28_6HisLiNDH2, respectively. 
Subsequently, insertion of a correct sequence in the vector was confirmed by complete 
sequencing and E. coli BL2I, BL21CodonPlus and Rosetta bacteria were transformed 
with these plasmids. Expression of the fusion proteins was performed by growing 
bacteria at 37ºC (temperature normally used for induction tests), during 8 hours 
following IPTG induction. 
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Figure 4. Recombinant protein expression in E.coli BL21CodonPlus. Expression of His6LimFRD and His6LiNDH2 
was analyzed by SDS-PAGE stained with coomassie blue. Protein from total extracts of  non-induced (NI), pellet 
fractions (P) and supernatant fractions (S) were loaded.  The position of the recombinant proteins is indicated. 
As shown in figure 4, both proteins were successfully expressed with the 
expected molecular weight, 129.7 kDa and 57.5 kDa for His6LimFRD and His6LiNDH2, 
respectively. In both cases no protein was observed in the non-induced extracts (NI), 
but following addition of 0.1 mM IPTG (inducing agent) protein expression is observed 
and it is predominantly present in the pellet fractions (P). These observations indicate 
that proteins are found either in the membrane or in insoluble forms. In order to try to 
express His6LimFRD and His6LiNDH2 in the soluble fraction of bacteria, we 
investigated the effect of several expression conditions such as concentration of IPTG, 
growth temperature, addition of different soluble compounds to the growth media and 
activation of chaperones, as summarized in figure 5. 
 
 
 
 
 
 
 
 
Figure 5. Conditions tested to improve the expression of the fusion proteins in the soluble fraction. 
---- 
Conditions tested to 
obtain soluble protein 
Expression of proteins 
in E. coli strains 
His6LimFRD 
His6LiNDH2 
Concentrations 
of IPTG  
0.1;0.2;0.5
mM 
Chaperones 
activation 
Ethanol; 
Ice bath 
Growth 
temperature 
30;25;20; 
17ºC 
Adition of 
soluble 
compounds 
Betaine 
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The results obtained were not encouraging, as seen in figure 6, with no 
significant increase in the amount of His6LimFRD and His6LiNDH2 as soluble proteins.  
 
 
 
 
 
 
 
 
 
 
Figure 6. Conditions tested for the improvement in soluble protein yield. E.coli expressing either His6LimFRD or 
His6LiNDH2 were grown under normal conditions (C) or subjected to 30 minutes cold shock (HS) or 30 minutes cold 
shock plus 10% Ethanol (HS+EtOH), as indicated. Bacteria were fractionated into pellet (P) and supernatant (S) and 
resolved by SDS-PAGE. The gel was stained with coomassie blue. 
In the experiment shown in figure 6, the condition tested for the improvement in 
His6LimFRD expression was thermal shock before IPTG induction. In the case of 
His6LiNDH2, the same condition was tested, as well as the addition of 10% ethanol to 
the bacterial culture prior to thermal shock. Both conditions will lead to chaperones 
activation increasing the probability of correct folding of the overexpressed proteins. 
Unfortunately, when we compare the expression of the fusion proteins with the 
respective expression controls, grown in normal conditions (without thermal shock and 
ethanol addition), we see similar results with no protein or a very low amount in the 
soluble fractions. Nonetheless, the soluble fractions of E. coli overexpressing strains 
were used in affinity chromatography purification process. No recombinant proteins 
were purified probably due to an insufficient amount of soluble protein. In light of these 
results, a new strategy was adopted taking advantage of the high amount of 
recombinant protein expressed in inclusion bodies (see figure 4). We cultured bacteria 
in large scale, fractionated them into pellet and supernatant and washed the inclusion 
bodies (pellets) with increasing concentrations of urea as a way to decrease 
contamination by other proteins (figure 7). 
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Figure 7. His6LimFRD expression in insoluble bodies.  Protein extracts from non-induced (NI), supernatant (S), and 
supernatants resulting from consecutive washes with 2, 3 and 8 M urea (S2M, S3M and S8M) were resolved by SDS-
PAGE and the gel was stained with coomassie blue. 
 
We found, firstly, His6LimFRD was successfully induced, secondly our protein is 
soluble in 8 M urea and lastly contaminants were removed with increasing urea 
concentration washes (2M and 3M). The same protocol was used for His6LiNDH2 (data 
not shown). The S8M supernatant was applied to an affinity chromatography column 
and the purification results can be seen in the chromatogram of figure 8 and in the 
respective SDS-PAGE analysis. 
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Figure 8. Purification of His-tagged LimFRD and LiNDH2 by affinity chromatography. A and C illustrate 
chromatograms obtained by affinity chromatography for His6LimFRD and His6LiNDH2 purification, respectively. B and D 
show SDS-PAGE analysis of the indicated fractions of the column purification. Sample loaded in column (S8M); flow 
through (FT); Fractions collected in the purification (F1, F7, F14, F20, F22, F26, F27, F30, F32, F39, F43). 
 
As shown in figure 8, no His6LimFRD protein was purified. An absorbance peak 
was expected after increasing imidazole concentrations in the elution buffer, however 
this was not observed. Analysis of the His6LiNDH2 chromatogram showed the same 
result. These observations were corroborated by SDS-PAGE analysis of several 
fractions of the purification procedure showing that most of the protein is present in the 
flow through (FT). The fact that the majority of the fusion protein is present in the FT 
means that the protein does not bind or binds weakly to the column in the conditions 
used. Therefore, we altered the procedure conditions by changing buffer composition 
including, urea, DTT, Triton X-100 or SDS. However, none of these attempts improved 
the yield of purified proteins.  
After all the unsuccessful attempts referred to above, we decided to change the 
protein purification strategy. In this case, the two proteins, His6LimFRD and 
His6LiNDH2, were purified using a preparative gel. For this we expressed the 
recombinant proteins as inclusion bodies, washed them with increasing urea 
concentrations and solubilized the final pellets with 8 M urea before gel separation, 
according to the protocol described in materials and methods. Afterwards, the purity of 
the samples was confirmed by SDS-PAGE, as shown in figure 9. 
 
FCUP/ICBAS 
Study of alternative NADH dehydrogenase and mitochondrial fumarate reductase in Leishmania Infantum 
32 
 
 
 
 
 
 
 
 
 
 
Figure 9. His6LimFRD and His6LiNDH2 purification by preparative gel. SDS-PAGE analysis of the final protein 
samples upon preparative gel purification. The gel was stained with coomassie blue. 
Both proteins were purified successfully by this method, with no visible 
contaminants. This material was used to immunize rats in order to produce antibodies 
against His6LimFRD and His6LiNDH2. 
 
4.2 Characterization of the antibodies against LimFRD and 
LiNDH2 
In order to study the specificity of the antibodies α-LimFRD and α-LiNDH2 
against L. infantum, total protein extracts were analyzed by Western Blot. In this 
experiment we used the E. coli His-tagged recombinant proteins as positive controls, 
and samples from different growth stages of L. infantum promastigotes from the wild 
type, the OE_LimFRD-cMyc and the OE_LiNDH2-cMyc strains (figure 10). Parasites 
from wt were transformed with multi-copy recombinant plasmids that lead to 
overexpression of either LimFRD or LiNDH2 proteins generating strains OE_LimFRD-
cMyc and OE_LiNDH2-cMyc, respectively. These plasmids confer resistance to G418 
and varying the drug amount we can modulate the overexpression of cMyc tagged 
LimFRD and LiNDH2 proteins. 
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Figure 10. Specificity of α-LimFRD and α-LiNDH2 antibodies. Western blot analysis upon SDS-PAGE using α-
LimFRD and α-LiNDH2 antibodies. PurifiedHis6LimFRD and His6LiNDH2 proteins were used as positive controls. Total 
protein extracts from L. infantum wt, OE_LimFRD-cMyc and OE_LiNDH2-cMyc strains grown at early (EL) and late 
logarithmic phases (LL) were analyzed. The same number of parasites (5x10
6
) was loaded in each lane.  
 
The analysis of figure 10 shows that α-LimFRD and α-LiNDH2 recognize the 
respective recombinant protein, showing thus, its specificity. Moreover, both antibodies 
recognize proteins in the different growth stages of the parasite, confirming that both 
proteins are expressed in these phases (early logarithmic and late logarithmic) in wild 
type, OE_LimFRD-cMyc and OE_LiNDH2-cMyc strains. In figure 10A, a band of 
approximately 129.7 kDa corresponding to the molecular weight of the LimFRD is 
detected in wild type and an increased expression is observed in the overexpressing 
strain. In figure 10B a band is recognized corresponding to the expression of LiNDH2, 
at 57.5 kDa, and an increased expression is detected in the respective overexpressing 
strain.  
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With this new tool, we can now characterize various aspects of LimFRD and 
LiNDH2 proteins. We began by addressing the expression of either protein in 
amastigotes through western blot analysis of protein extracts from wild type (figure 11). 
 
                               
 
 
 
 
 
 
 
 
Figure 11. LimFRD and LiNDH2 are expressed in axenic amastigotes of L. infantum. Total protein extracts  from wt 
promastigotes (P) grown at early (EL) and late logarithmic (LL) phases and amastigotes (A) grown at logarithmic phase 
were analyzed by western blotting with antisera against LimFRD (A) or LiNDH2 (B). The same number of parasites 
(5x10
6
) was loaded in each lane. 
 
Western blot analysis shows the expression of both proteins, LimFRD and 
LiNDH2, in amastigotes (figure 11). Our results reveal that both proteins are expressed 
in axenic amastigote forms with the expected molecular weights - 129.7 kDa for 
LimFRD and 57.5 kDa for LiNDH2- indicating that no alterations in the proteins occur in 
the different forms of the parasite. No significant differences were observed in LimFRD 
expression between amastigotes and promastigotes, although early log promastigotes 
seem to have a slight increase in expression of LiNDH2. 
The expression of cMyc tagged LimFRD in the OE_LimFRD-cMyc strain was 
evaluated by western blotting analysis upon growth with increasing concentrations of 
G418. As we can see in figure 12, increased G418 concentration does not led to a 
corresponding increase in tagged-LimFRD protein expression and thus, the lowest 
concentration of G418 was used henceforward. The same result was verified for 
tagged-LiNDH2 (data not shown).  
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Figure 12. Increasing G418 concentrations does not affect expression of tagged-LimFRD. Expression of LimFRD 
in the OE_LimFRD-cMyc was evaluated by western blotting with antisera against cMyc, LimFRD and LiNDH2. Wild type 
and OE_LiNDH2-cMyc promastigotes strains were grown at early (EL) logarithmic phase and OE_LimFRD-cMyc were 
grown at early (EL) and late (LL) logarithmic phases with increasing concentrations of G418. The same number of 
parasites (5x10
6
) was loaded in each lane. 
 
4.3 Localization of LimFRD and LiNDH2 proteins in L. infantum 
 To determine the subcellular localization of L. infantum LimFRD and LiNDH2 
proteins, digitonin assay, immunofluorescence and carbonate extraction assays were 
carried out. 
4.3.1 Digitonin/proteinase K assay 
 Wild type parasites were used in order to determine the subcellular localization 
of LimFRD and LiNDH2 endogenous protein. Based on the differential composition of 
the cellular membranes, the subcellular compartments are differentially permeabilized 
by the non-ionic detergent digitonin, with glycosomes and mitochondrial membranes 
being more resistant to this detergent. After solubilization with digitonin, proteinase K 
was added to degrade accessible proteins. The patterns of extraction and degradation 
of LimFRD and LiNDH2 were compared with the following markers: mTPx, LiTryS and 
arginase. The mitochondrial peroxiredoxin (mTPx) (64) was used as a mitochondrial 
marker, trypanothione synthetase (LiTryS) (65) as a cytosolic protein and arginase (66) 
as a glycosomal marker.  
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Figure 13. Protease accessibility upon digitonin solubilization of wt parasite membranes.  Protein samples 
resulting from the permeabilization of wt promastigotes with increasing concentrations of digitonin in the presence of 
proteinase K were analyzed by western blotting with antibodies against the indicated proteins. Arginase, mTPx and 
LiTryS were used as controls.  
 
Results in figure 13 show that LiNDH2 protein is digested at approximately 1 mg 
DIG/mg protein and the same pattern is observed for the mitochondrial marker mTPx 
and thus, we concluded that LiNDH2 is a mitochondrial protein (figure 13), as 
expected. On the other hand, LimFRD protein is insensitive to proteinase K 
degradation and hence it is not possible to conclude about its subcellular localization 
by this procedure. To confirm that LimFRD is indeed resistant to proteinase K, we 
tested its sensitivity to protease degradation in different assay conditions (figure 14). 
We used different detergents to solubilize wt parasites (DIG, Nonidet P-40, SDS or 
Triton X-100) and different proteases (PK and trypsin). Figure 14 shows that PK only 
digested LimFRD when in the presence of SDS, thus, when LimFRD is denatured and 
that in all the other conditions LimFRD is resistant to degradation as confirmed by 
comparison with the control LiNDH2. Moreover, even in the presence of SDS LimFRD 
is resistant to trypsin degradation. 
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Figure 14. LimFRD is resistant to proteases degradation. Wild type promastigotes were solubilized with 1% of 
digitonin (DIG), Nonidet P-40 (NP40), sodium dodecyl sulphate (SDS) or Triton X-100 (TX-100) detergents in the 
presence of either proteinase K (PK) or trypsin (T). The resulting samples were analyzed by western blotting with 
antiserum against LimFRD and LiNDH2. 
Due to the experimental limitation referred above, we decided to use 
OE_LimFRD-cMyc parasites in order to determine the subcellular localization of cMyc 
tagged LimFRD. Although we knew that the endogenous protein is resistant to 
degradation by PK, the behavior of the overexpressed protein was not known.  
 
  
 
 
 
 
 
 
 
 
Figure 15. Protease accessibility upon digitonin solubilization of OE_LimFRD-cMyc parasite membranes.  
Protein samples resulting from the permeabilization of OE_LimFRD-cMyc promastigotes with increasing concentrations 
of digitonin in the presence of proteinase K were analyzed by western blotting with antibodies against the indicated 
proteins. mTPx and LiTryS were used as controls.  
Curiously, the results of protease accessibility (figure 15) show that LimFRD-
cMyc was digested by PK at approximately 1 mg DIG/mg protein in a pattern similar to 
that observed for the mitochondrial marker mTPx, leading us to concluded that 
LimFRD-cMyc protein is located in the mitochondria. However, the endogenous protein   
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maintains its resistance to degradation as previously observed for the wild type (figure 
13). The different behavior of the endogenous and tagged LimFRD proteins to PK 
suggests that, although both can be localized in the mitochondrion, differences in the 
conformation or post-translational modification should exist between them.  
 
4.3.2 Immunofluorescence 
 To confirm the subcellular localization of LiNDH2 and LimFRD proteins in L. 
infantum, promastigotes cultured during 3 days were analyzed by indirect 
immunofluorescence. DAPI was used to stain the nucleus and kinetoplast (blue), an 
antibody against mTPx was used to detect the mitochondrion (red), and antibodies 
against the LiNDH2, the LimFRD and the LimFRD-cMyc to stain LiNDH2, LimFRD and 
LimFRD-cMyc proteins (green).  
 
4.3.2.1 Localization of LiNDH2 
OE_LiNDH2-cMyc L. infantum promastigotes were labeled with α-LiNDH2 and 
α-mTPx antibodies and analyzed by immunofluorescence. As shown in figure 16, the 
LiNDH2 signal completely overlaps with that of mTPx, confirming that LiNDH2 is a 
mitochondrial protein, in accordance with the results obtained in digitonin/proteinase K 
assays.  
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Figure 16. Localization of LiNDH2. OE_LiNDH2-cMyc promastigotes were labeled with DAPI (A), α-LiNDH2 (B) and α-
mTPx (C). The merged images are shown in panel (D). The cells were visualized in a Zeiss Axio Imager Z1 microscope. 
 
4.3.2.2 Localization of LimFRD 
In order to investigate the subcellular localization of LimFRD we performed 
immunofluorescence assays using the OE_LimFRD-cMyc promastigotes labeled with 
α-LimFRD and α-mTPx. The signal obtained with α-LimFRD is faint and does not totally 
overlap with that observed for the mitochondrial marker, α-mTPx (figure 17), rendering  
the precise LimFRD localization unclear. This faint staining may be due to the fact of 
the α-LimFRD antibody has been produced against the denatured protein and thus 
may not recognize LimFRD in immunofluorescence assays. In order to overcome this 
possible  problem, we  used  α-cMyc to recognize the tagged LimFRD overexpressed 
protein (figure 18).  
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Figure 17. Localization of LimFRD. OE_LimFRD-cMyc promastigotes were labeled with DAPI (A), α-LimFRD (B) and 
α-mTPx (C). The merged images are shown in panel (D). The cells were visualized in a Zeiss Axio Imager Z1 
microscope. 
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Figure 18. Localization of cMyc tagged-LimFRD. OE_LimFRD-cMyc promastigotes were labeled with DAPI (A), α-
cMyc (B) and α-mTPx (C). The merged images are shown in panel (D). The cells were visualized a Zeiss Axio Imager 
Z1 microscope. 
 
As can be observed in figure 18, LimFRD-cMyc protein is detected in the 
mitochondrion of most parasites but its distribution does not entirely co-localize with 
mTPx staining. We confirmed that this protein was not localized in glycosomes, since 
no immunostaining overlap was observed between LimFRD-cMyc and a glycosomal 
marker in an immunofluorescence assay (data no shown). Our results indicate that 
LimFRD-cMyc localizes to the mitochondrion. 
 
4.3.3 LimFRD is a soluble protein and LiNDH2 is associated with the 
mitochondrial membrane 
To investigate whether LimFRD and LiNDH2 are associated with the 
mitochondrial membranes or if they are instead soluble proteins, alkaline carbonate 
extraction was performed. It was previously described that in some trypanosomatids 
mFRD is a hydrophilic protein associated with the mitochondrial membrane (62). 
Moreover, LiNDH2 orthologous have being described as either integral membrane 
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proteins (67) or extrinsic membrane proteins (51). Wild type and OE_LimFRD-cMyc 
promastigotes were used for carbonate extraction. 
 
 
 
 
 
 
 
 
Figure 19. LimFRD is soluble and LiNDH2 is found associated with the membrane.  Wild type and OE_LimFRD-
cMyc promastigotes were extracted with 0.1M Na2CO3 and total protein extracts (TE), supernatants (S) and membrane 
pellets (P) resulting from fractionation were analyzed by western blotting using antibodies against the indicated proteins. 
Figure 19 shows that LimFRD is distributed between the pellet and the 
supernatant in both the wt and the OE_LimFRD-cMyc strains. This result indicates that 
LimFRD, although a hydrophilic protein, seems to have an interaction with the 
membrane. However, looking carefully to the soluble controls, mTPx and LiTryS, we 
notice that both proteins are distributed between the pellet and the supernatant 
fractions. A possible explanation for this observation (given that mTPx and LiTryS are 
known soluble proteins) is contamination of the pellet fractions with intact parasites. 
Considering these results, we may conclude that both LimFRD and LimFRD-cMyc are 
soluble proteins. On the other side, LiNDH2 is mainly present in the pellet fraction, 
indicating that this protein is associated with the mitochondrial membrane. LiZIP1 is a 
transmembrane transporter that is detected only in the pellet fraction, as expected.  
 
 
4.4 Enzymatic assays in bacteria and parasite membranes 
 Enzymatic assays were performed attempting to determine the kinetic 
parameters of LimFRD and LiNDH2 enzymes, in order to characterize them. Initially, 
measurements of NADH-Q1 and NADH-fumarate reductase activities were performed 
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in bacterial membranes from non-induced controls and induced overexpressing strains. 
Yet, no differences between the analyzed strains were detected. This suggests that 
either the fusion proteins were not active in the bacterial membranes or they have 
aggregated during membrane preparation, given that alterations in membrane 
properties were verified.  
Alternatively, we attempted to measure the same NADH-Q1 and NADH-
fumarate reductase activities using parasite membranes from wt, OE_LimFRD-cMyc 
and OE_LiNDH2-cMyc strains. Nonetheless, once again, the same difficulty was 
observed since, although we could measure NADH consumption, alterations between 
wt and the overexpression strains were not observed. Taking these results into 
account, respiratory assays were performed to try to overcome this drawback. With 
these assays we wanted to characterize the differences between wt, OE_LimFRD-
cMyc and OE_LiNDH2-cMyc strains in order to ascertain the function of LimFRD and 
LiNDH2 in the respiratory chain of L. infantum.  
 
4.5 Oxygen consumption in L. infantum  
In order to study the effects of overexpressing LimFRD and LiNDH2 on the 
respiration process we measured oxygen consumption in L. infantum with an oxygen 
electrode. Moreover, we evaluate the effects of respiratory chain inhibitors namely, 
rotenone, TTFA and KCN as inhibitors of complex I, II and IV, respectively. In figure 20, 
we can observe an example of the action of the inhibitors in oxygen consumption by 
intact L. infantum parasites, obtained from O2view software.  
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Figure 20. OE_LiNDH2-cMyc promastigotes respiration. Representative assay of basal oxygen consumption by 
promastigotes upon sequential inhibition with 2 mM TTFA, 60 µM rotenone and 1mM KCN to the reaction medium. 
Results were acquired with O2view software. Percentages of inhibition by TTFA and KCN were determined relatively to 
the initial oxygen consumption rate. Rotenone inhibition was calculated relatively to oxygen consumption upon TTFA 
inhibition. 
 
As we can see in the figure above, addition of inhibitors leads to a decrease in 
the slope of the line, which reflects a decrease in oxygen consumption. After the 
addition of TTFA a slope decrease is observed, meaning that complex II is involved in 
O2 consumption. Moreover, when rotenone is added the inhibition of oxygen 
consumption is not significant indicating a negligible contribution of complex I to 
respiration. On the other hand, reduction of O2 is mainly performed by complex IV, 
since KCN almost completely inhibits respiration (figure 20). 
In figure 21, basal oxygen consumption and oxygen consumption upon 
inhibition by TTFA and KCN were determined for intact L. infantum promastigotes of 
the wt, OE_LiNDH2-cMyc and OE_LimFRD-cMyc strains, grown to the logarithmic 
phase. The values of basal oxygen consumption (nmol O2.min
-1.mg-1) and the 
percentages of inhibition by 2 mM TTFA and 1 mM KCN, are summarized in table 6. 
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Figure 21. Oxygen consumption by L. infantum promastigotes. Basal oxygen consumption and oxygen 
consumption upon TTFA and KCN inhibition of the wt, OE_LiNDH2-cMyc and OE_LimFRD-cMyc parasites were 
measured polarographically at RT with a Clark-type oxygen electrode.  Results were evaluated with O2view software. 
Errors bars represent standard deviation. ns- non significant, **P<0.01 as calculated by t-test in Graph Pad Prism. 
 
 
Table 6. Basal oxygen consumption in L. infantum promastigotes. Basal oxygen consumption of the wt, 
OE_LiNDH2-cMyc and OE_LimFRD-cMyc parasites grown for 3 days was determined. TTFA and KCN inhibition is 
shown as percentage of the basal rate. Data are expressed as average ± SD of n independent experiments.  
Strains Basal O2 consumption   
(nmol O2.min
-1
.mg
-1
) 
TTFA inhibition 
(%) 
KCN inhibition 
(%) 
WT 
OE_LiNDH2-cMyc 
OE_LimFRD-cMyc 
16.66 ± 4.71 (n= 11) 
22.23 ± 3.27 (n= 6) 
15.53 ± 4.99 (n=8) 
58.00 
58.90 
49.30 
90.70 
91.10 
73.30 
 
 
The results show that the OE_LiNDH2-cMyc strain displays the highest basal 
oxygen consumption reaching 22.23 ± 3.27 nmol O2.min
-1.mg-1protein followed by wt 
(16.66 ± 4.71 nmol O2.min
-1.mg-1protein) and the OE_LimFRD-cMyc (15,53 ± 4,99 nmol 
nmol O2.min
-1.mg-1protein), as illustrated in figure 21 and table 6. These results suggest 
that overexpression of these NADH oxidizing enzymes has some impact on 
mitochondrial respiration. The susceptibility of the different L. infantum promastigotes 
ns 
** 
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to mitochondrial respiratory chain inhibitors was also evaluated. Rotenone, an inhibitor 
of complex I does not affect oxygen consumption, suggesting that complex I is not 
involved in basal oxygen consumption under the tested conditions (data not shown). 
Inhibition with TTFA has a similar behavior in wt and OE_LiNDH2-cMyc and a slightly 
minor effect in OE_LimFRD-cMyc respiration (Table 6). When we used KCN the 
inhibitory effect verified was approximately the same for wt and OE_LiNDH2-cMyc (90-
91% inhibition) and, once again, OE_LimFRD-cMyc was less inhibited (74%). 
The oxygen consumption inhibited by TTFA (Figure 22), a complex II inhibitor, 
can be considered as the respiratory rate contributed by complex II activity (basal 
oxygen consumption-TTFA). 
 
 
 
 
 
 
 
 
 
 
 
Figure 22. Oxygen consumption inhibited by TTFA. Oxygen consumption from wt, OE_LiNDH2-cMyc and 
OE_LimFRD-cMyc parasites grown during 3 days was measured polarographically at RT with a Clark-type oxygen 
electrode and results were evaluated with O2view software. 
 
As seen in figure 22 and table 7 the major oxygen consumption dependent on 
complex II activity is achieved by OE_LiNDH2-cMyc and wt (13.10 ± 3.26 and 9.67 ± 
2.85 nmol O2.min
-1.mg-1protein, respectively), while the lowest was verified in 
OE_LimFRD-cMyc being 7.66 ± 1.83 nmol O2.min
-1.mg-1 protein, suggesting that this 
complex is less involved in respiration in this strain. Moreover, overexpression of 
LiNDH2 leads to an increase in basal oxygen consumption accompanied by an 
increase contribution of complex II. 
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Table 7.  Effect of the respiratory chain inhibitors TTFA and KCN in oxygen consumption.  Data are expressed as 
average ± SD of n independent experiments. Oxygen consumption was measured polarographically at RT with a Clark-
type oxygen electrode and results were evaluated with O2view software. 
Strains     Basal O2 consumption    Basal – TTFA TTFA – KCN 
 (nmol O2.min
-1
.mg
-1
) 
WT 16.66 ± 4.71 (n=11)   9.67 (n=7)  5.44 (n=6) 
OE_LiNDH2-cMyc 22.23 ± 3.27 (n=6) 13.10 (n=5)   7.15 (n=6) 
OE_LimFRD-cMyc 15.53 ± 4.99 (n=8)  7.66 (n=6)   3.74 (n=7) 
 
 
Figure 23 illustrates the oxygen consumption attributed to enzymes able to feed 
electrons into quinone of the ERC, namely complex I, LiNDH2, G3PDH and probably 
other uncharacterized reductases, not sensitive to complex II inhibitors. This respiratory 
rate is determined as the KCN sensitive and TTFA resistant oxygen consumption 
(TTFA-KCN). The highest rate is observed for OE_LiNDH2-cMyc (7.15 ± 1.65 nmol 
O2.min
-1.mg-1), suggesting that it is the result of overexpressing LiNDH2. In wt and 
OE_LimFRD-cMyc the TTFA-KCN rates were smaller (5.44 ± 1.12 and 3.74 ± 1.46 
nmol O2.min
-1.mg-1, respectively) than in OE_LiNDH2-cMyc. The low rate observed in 
OE_LimFRD-cMyc is probably due to a decreased contribution of LiNDH2 in oxygen 
consumption resulting from the overexpression of LimFRD, an enzyme involved in 
NADH oxidation as LiNDH2 but not in a KCN sensitive pathway. 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Oxygen consumption sensitive to KCN and resistant to TTFA. Oxygen consumption from wt, 
OE_LiNDH2-cMyc and OE_LimFRD-cMyc parasites grown for 3 days was measured polarographically at RT with a 
Clark-type oxygen electrode and results were evaluated with O2view software. 
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4.6 L. infantum sensitivity to OXPHOS inhibitors 
To test the sensitivity of L. infantum promastigotes growth to OXPHOS 
inhibitors we used wt, OE-LiNDH2_cMyc and OE-LimFRD_cMyc strains according to 
materials and methods and performed a comparative analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Inhibition of proliferation of L. infantum promastigotes by inhibitors of the OXPHOS. Promastigotes 
were cultured during three days in the presence of inhibitors (1 mM for KCN, 20 and 60 µM for rotenone, 2 mM for 
TTFA, 2 µg.ml
-1
 for antimycin A, 2 µg.ml
-1
 for oligomycin and 5 mM for SHAM). The final growth was evaluated by 
measuring OD600nm using a spectrophotometer. 
 
As we can see, in the presence of KCN or 60 µM rotenone, L. infantum growth 
was inhibited by about 40% in comparison to the controls without inhibitors. A similar 
pattern of growth inhibition was observed for SHAM, antimycin A or TTFA, which 
resulted in approximately 80% growth inhibition. On the other side, oligomycin or low 
rotenone concentrations (20 µM) did not inhibit parasite growth with oligomycin even 
promoting parasite proliferation (figure 24). This increase in proliferation is more 
pronounced in OE_LimFRD-cMyc strain. The pattern of growth inhibition by OXPHOS 
drugs is similar in all the strains analyzed with only a minor difference upon oligomycin 
addition. 
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Discussion 
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Mitochondrial fumarate reductase (mFRD) and alternative NADH 
dehydrogenase (NDH2) are proteins involved in mitochondrial metabolism through 
NADH oxidation. mFRD was identified in prokaryote and eukaryote organisms. This 
protein is usually a multi-subunit complex able to use reduced quinone as an electron 
donor that in eukaryotes is associated to the mitochondrial membrane. In 
trypanosomatids, mFRD is a single polypeptide enzyme that uses NADH to reduce 
fumarate and thus is accountable for matrix NADH oxidation. NDH2 was identified in 
several fungi, plants and primitive eukaryotic cells and can be localized in the external 
or internal face of the inner mitochondrial membrane. Knowledge of the exact 
localization of NDH2 in the mitochondria is important to understand if this enzyme 
oxidizes NADH resulting from catabolic processes that occur in the mitochondria or 
NADH produced in the cytosol. In the first case the enzyme is located at the inner face 
of the inner membrane of the organelle and can perform the same role as complex I 
with the exception that this last one also has proton translocation activity. In the second 
case, the enzyme is located in the outer face of the inner membrane and does not 
replace complex I, being responsible for the regeneration of cytosolic NAD+. These 
enzymes are absent from mammalian cells, and this fact makes them potential drug 
targets to control diseases caused by trypanosomatids (16,41).  
To understand the role of LimFRD and LiNDH2 within the mitochondrial 
respiratory chain we set out to identify their subcellular localization and to characterize 
the overexpressing strains, OE_LimFRD-cMyc and OE_LiNDH2-cMyc. For this 
purpose, we studied the expression and localization of the proteins in L. infantum 
parasites, and analyzed changes in oxygen consumption and parasite growth mediated 
by known oxidative phosphorylation inhibitors.  
Regarding the expression of LimFRD and LiNDH2 proteins in L. infantum, we 
conclude that both proteins are expressed in different forms of the parasite 
(promastigote and amastigote) and in different growth stages (early log and late log), 
suggesting that no alterations in the proteins occur in the different forms of the parasite. 
Furthermore, expression of LiNDH2 and LimFRD in amastigotes validates the potential 
value of these proteins as drug targets.   
Both enzymes are predicted as mitochondrial proteins by in silico analysis. 
Subcellular localization of the proteins was determined with several biochemical assays 
confirming that both proteins are located in the mitochondria. LimFRD is a soluble 
enzyme as described for its orthologous in T. brucei (22). LiNDH2 is associated to the 
mitochondrial inner membrane although its exact localization, with catalytic sites facing 
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the external intermembrane space or the internal mitochondrial matrix of L. infantum 
parasites, requiring further investigation. Given that the internal NDH2 enzyme of S. 
cerevisiae was described as a monotopic protein (34), we speculate that LiNDH2 may 
also be an integral membrane protein that interacts only to one side of the inner 
mitochondrial membrane. 
The kinetic parameters of LimFRD and LiNDH2 enzymes were not determined 
due to experimental difficulties. Overexpression of both proteins in either E. coli or L. 
infantum did not result in differences in their specific biochemical activities when 
compared to the control, preventing us to biochemically characterize any of the 
proteins. Though the experimental procedures involved the preparation of membranes, 
a harsh task, we were able to measure NADH oxidation either using Q1 or fumarate as 
electron acceptors. Yet, no specific inhibitor for any of the enzymes is available what 
makes it difficult to identify the NADH oxidation activity performed by LiNDH2 or 
LimFRD, as no increase in the respective activities was observed upon 
overexpression.  
To circumvent this difficulty, oxygen consumption assays were performed 
comparing overexpressing strains with the wild type. Our data shows that the basal 
oxygen consumption is higher upon LiNDH2 overexpression, in the OE_LiNDH2-cMyc, 
than in wt and OE_LimFRD-cMyc although in all the strains complex II, III and IV are 
involved in respiration. The higher respiration in OE_LiNDH2-cMyc is associated with 
an increase in complex II activity and an increase in the activity of enzymes that feed 
electrons into the first entry point of the respiratory chain (including NDH2, G3PDH and 
complex I). Since inhibition of oxygen consumption by rotenone, a specific inhibitor of 
complex I, is very low we assumed that either complex I is not being expressed under 
the experimental conditions used or rotenone is not able to inhibit the L. infantum 
enzyme. This low inhibition was observed for all the tested strains and previously 
described as a characteristic of several trypanosomatids respiration (40,62).  Moreover, 
it was shown that knocking down NDH2 in procyclic T. brucei results in increased 
G3PDH activity (61,68).  Hypothesizing that the reverse situation may occur, we would 
expect that overexpression of LiNDH2 in the OE_LiNDH2-cMyc strain decreases 
G3PDH activity and thus, LiNDH2 is the main enzyme feeding electrons into the first 
entry point of the respiratory chain (oxygen consumption inhibited by KCN and resistant 
to TTFA, Figure 23). This interrelationship between NDH2 and G3PDH was previously 
described also for yeast where it was shown that both external NADH dehydrogenases 
and G3PDH compete for electron supply to the respiratory chain (69,70). 
FCUP/ICBAS 
Study of alternative NADH dehydrogenase and mitochondrial fumarate reductase in Leishmania Infantum 
52 
 
Overexpression of LimFRD leads to a decreased rate of oxygen consumption 
with an increased resistance to the complex IV inhibitor KCN (Figure 21). This lower 
sensitivity of OE_LimFRD-cMyc to KCN suggests that oxygen consumption is not 
totally used by the respiratory chain being probably associated with ROS production. 
The LimFRD enzyme produces succinate via fumarate oxidation, implying that, upon 
overexpression and if fumarate is present in limiting amounts, ROS can be produced. 
Previous findings in T. brucei indicate that, in the absence of fumarate, FRD becomes 
an intracellular source of reactive oxygen species such as superoxide anion and 
hydrogen peroxide (32). 
The increase in complex II activity observed in OE_LiNDH2-cMyc may be 
associated with an increase in Krebs cycle activity as described before for procyclic T. 
brucei (71). The diminished basal oxygen consumption upon LimFRD overexpression 
can result from the decreased activity of NDH2, since both enzymes oxidize the NADH 
substrate. Consequently, fewer electrons from NADH enter the respiratory chain while 
succinate production increases as may increase the electron flux through complex II. 
Because the activity of complex II in the OE_LimFRD-cMyc strain is even lower than in 
the wild type we speculate that succinate is probably being excreted.   
Based on the oxygen consumption results, the effects of OXPHOS inhibitors in 
L. infantum promastigotes growth were evaluated. As referred above, complex I 
appears to be absent in L. infantum promastigotes (Figure 20). However, elevated 
rotenone concentrations (60 µM) inhibited parasite growth by around 40% while smaller 
rotenone concentrations have no effect on growth. Previous studies showed that lower 
concentrations of rotenone were sufficient for growth inhibition of other Leishmania spp 
(14). Our results suggest that inhibition of L. Infantum growth by rotenone is probably 
due to an unspecific effect of the drug. In fact, it was previously described that high 
amounts of rotenone can inhibit FRD (62). 
Growth inhibition using KCN is expected to be close to total, as complex IV 
seems to be the only respiratory enzyme reducing oxygen. Surprisingly, only about 
40% growth inhibition was observed for all the 3 strains in the presence of KCN (Figure 
24), indicating that either the amount of inhibitor is not sufficient for complete inhibition 
of growth or an alternative pathway exists to reduce oxygen, which is induced in the 
presence of KCN. In fact, it is known for a long time that fungi, plants and protozoa 
possess an alternative oxidase, able to replace complex III and IV function. This 
alternative oxidase is present in T. brucei procyclic and bloodstream forms and is 
inhibited by SHAM (38), but was not described for Leishmania spp. We looked for such 
an enzyme through genome mining in L. infantum using the sequence of AOX from T. 
FCUP/ICBAS 
Study of alternative NADH dehydrogenase and mitochondrial fumarate reductase in Leishmania Infantum 
53 
 
brucei. A gene encoding a putative alternative oxidase was identified in the genome of 
L. infantum (LinJ36.4980) and it is conserved in many other trypanosomatids including 
T. brucei (where two alternative oxidases exist). The protein encoded by the referred 
gene was identified in the mitochondrial proteome of T. brucei (72). Surprisingly, SHAM 
inhibits L. infantum growth almost completely as observed for antimycin A and TTFA. 
However, a huge concentration of SHAM (5 mM) was tested what could result in 
unspecific effects. Using lower concentrations of inhibitor a less drastic effect on 
parasite growth was observed (data not shown). 
The lethal effect of TTFA (inhibitor of complex II) and antimycin A (inhibitor of 
complex III) suggests that both complex II and complex III are essential for L. infantum 
promastigote survival in the tested conditions in the presence of glucose. In procyclic 
forms of T. brucei, complex II was shown to be essential for parasites survival only in 
glucose-depleted conditions (71). The great inhibition by the complex III inhibitor 
emphasizes the importance of this enzyme for L. infantum, whereas no need for this 
complex is described for other trypanosomatids (35). In fact, the result obtained with 
antimycin A and KCN is difficult to reconcile, as both inhibitors should have the same 
effect on growth. A possible explanation for this discrepancy is that only inhibition by 
KCN (complex IV) induces the hypothetical alternative oxidase. Another puzzling 
observation was the effect of the inhibitor of ATP synthase, oligomycin, which instead 
of reducing growth by decreasing ATP production, leads to increased proliferation of 
the parasites. This indicates that ATP production can occur by pathways other than 
OXPHOS, probably glycolysis. Moreover, the increased proliferation can be due to a 
transition for a more glycolytic metabolism instead of the predominantly oxidative 
phosphorylation. This recalls the situation of cancer cells where the increased glycolytic 
flux, associated with a decreased oxidative metabolism, results in cell proliferation (73). 
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The energetic metabolism of Leishmania parasites is a complex issue and its 
study is vital for the conception of possible ways to block it. To dissect the relevance of 
LimFRD and LiNDH2 in L. infantum metabolism, mutant parasites in either LimFRD 
(three copies in the genome) or LiNDH2 (two copies in the genome) encoding genes 
are required. To obtain the knockout mutants, the respective ORF is replaced by a 
gene that confers resistance to a drug. However, sometimes knockout mutants are not 
viable, indicating that the gene may be essential, and deletion of all the gene copies is 
only possible upon episomal expression of the protein.  
Another important aspect that deserves further investigation is the exact 
localization of LiNDH2 protein, either facing the mitochondrial matrix or the 
intermembrane space. This issue is of utmost importance as it will define LiNDH2 as 
the alternative to complex I (internal enzyme) or as an enzyme that oxidizes cytosolic 
NADH, and thus cannot complement for the absence of complex I. To address this 
question, we will investigate the ability of LiNDH2 to complement the phenotypes of 
ndi1 or the double mutant nde1/nde2 of S. cerevisiae. 
The thorough characterization of the respiratory chain of L. infantum 
amastigotes will also be pursued and compared to the promastigotes pathway. 
Moreover, it will be important to elucidate the effect of SHAM and KCN in 
promastigotes growth, namely to investigate the induction of a putative alternative 
oxidase. 
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Figure 25. Representation of the expression plasmids pET28_6HisLimFRD and pET28_6HisLiNDH2. This vector 
was used for expression of L.infantum mitochondrial fumarate reductase and alternative NADH dehydrogenase. 
 
 
 
 
 
 Table 8. Values used for determination of the oxygen consumption rates of the indicated strains. The numbers in red were excluded from the analysis.  
 
 
  
nmol O2.min
-1.mg-1 
Basal oxygen consumption + TTFA + TTFA+KCN 
WT 
OE_LimFRD-
cMyc 
OE_LiNDH2-
cMyc 
WT 
OE_LimFRD-
cMyc 
OE_LiNDH2-
cMyc 
WT 
OE_LimFRD-
cMyc 
OE_LiNDH2-
cMyc 
26.20 22.72 25.94 
   
0.40 1.92 1.85 
15.04 14.40 21.31 
 
9.39 11.23 
 
5.55 3.14 
20.85 17.68 27.33 5.81 6.23 6.79 0.85 2.51 0.72 
18.09 22.57 18.75 5.90 10.74 
 
0.66 4.71 
 
15.1 10.27 19.19 
 
7.83 4.97 
 
5.23 0.04 
10.85 12.42 23.66 2.60 6.61 9.61 
 
5.38 1.52 
19.13 13.91 22.63 10.20 6.43 13.03 3.33 3.65 4.57 
19.21 10.30 18.99 8.58 
  
1.80 
  
20.00 
  
10.42 
 
11.25 5.42 2.25 
11.70 
  12.50 
Average 16.66 15.53 22.23 6.99 7.87 9.13 1.55 4.14 1.97 
SD 4.71 4.99 3.27 2.86 1.84 3.26 1.12 1.46 1.65 
  
 
 
 
 
 
